Jamaica Plain, MA, United States of America

Filiberto Cedeno Laurent

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Filiberto Cedeno Laurent. Retrieved from https://idiyas.com/inventor/filiberto-cedeno-laurent

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Filiberto Cedeno Laurent: Innovator in Immunology

Introduction

Filiberto Cedeno Laurent is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of immunology, particularly through his innovative research and development of therapeutic agents.

Latest Patents

Cedeno Laurent holds 1 patent for his work on Galectin-immunoglobulin chimeric molecules. This patent describes Galectin-1/Ig fusion constructs and methods of use, which are applicable in diagnostic and biomedical assays. These constructs serve as therapeutic agents for treating conditions associated with immune dysfunction, such as autoimmune diseases and cancers.

Career Highlights

He is currently affiliated with Brigham and Women's Hospital, Inc., where he continues to advance his research in immunology. His work has the potential to impact the treatment of various immune-related conditions significantly.

Collaborations

Cedeno Laurent collaborates with esteemed colleagues, including Steven R Barthel and Charles J Dimitroff, enhancing the scope and depth of his research endeavors.

Conclusion

Filiberto Cedeno Laurent's innovative work in the field of immunology exemplifies the importance of research in developing new therapeutic solutions. His contributions are paving the way for advancements in the treatment of immune dysfunction and related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…